At booth #2501, the company is set to demonstrate its end-to-end ecosystem, focusing on the intersection of microbiology, molecular diagnostics, and laboratory informatics. Key technologies on display include the BIOFIRE FILMARRAY TORCH and SPOTFIRE systems, the VITEK MS PRIME mass spectrometry platform, and the VIDAS 3 automated immunoassay system. Beyond hardware, the company plans to showcase its IT solutions and consultancy services aimed at digital transformation in clinical settings.
Educational programming remains a core component of the company’s presence. Experts will host two symposiums on July 28, addressing the shift toward point-of-care vaginitis diagnostics and the clinical impact of multiplex PCR panels for gastroenteritis. On July 29, the firm will convene a panel discussion titled "The Power of Diagnostics: How Delays Impact Patients and Providers," which explores the systemic consequences of diagnostic inaccuracies for underserved populations. Headquartered in France, bioMérieux reported 2025 revenues of €4.1 billion and continues to expand its global footprint across 46 countries.
Comments (0)
No comments yet. Be the first!